TrialFind
Search
About
Saved trials
Back to results
Terminated
Phase 2
Liposomal Doxorubicin, Trastuzumab, and Docetaxel in HER2 Positive Metastatic Breast Cancer
NCT00377780
What is this trial?
Generating plain-language summary...
Am I eligible?
Generating eligibility summary...
What's involved?
Summarizing study design...
Where and how to apply
Primary location
Ziekenhuis Rijnstate
Arnhem, Netherlands
+6 additional locations
View on ClinicalTrials.gov
Official details
Liposomal Doxorubicin, Trastuzumab, and Docetaxel in HER2 Positive Metastatic Breast Cancer — TrialFind